Page 7

K - Ameliorate Neuropathic Pain

Recognized Content Experts Likely to Influence Practice in the Next Five Years 1. Ian Beauprie, MD (Anaesthesia), Halifax: Interventional pain management. 2. Robert Brownstone, PhD MD (Neurosurgery), Halifax: Neurosurgical interventions for pain management. 3. John Clark, MD (Anesthesiology), Halifax: Chronic pain management and pain policy in Canada. 4. Cathy Craven, MD (Physiatry), Toronto: Exploring the role of vitamin D in pain management. 5. Karen Ethans, MD (Physiatry), Winnipeg: Clinical management of NeP. 6. Andrea Furlan, PhD MD (Physiatry), Toronto: Implementation of the Canadian Narcotic Guidelines. 7. Sander Hitzig, PhD (Psychology), Toronto: Psychosocial factors influencing the development and maintenance of SCI-related chronic pain. 8. Mojgan Hodaie, MD (Neurosurgery), Toronto: Sacral stimulation, dorsal rhizotomy, deep brain stimulation. 9. Judi Hunter, PhD (Physiotherapy), Toronto: Development of a thermal grill to enable bedside assessment of neuropathic pain. 10. Howard Intrater, MD (Anaesthesia), Winnipeg: Interventional pain management. 11. Lin Jacques, MD (Neurosurgery), Montréal: Surgical management of NeP. 12. Joel Katz, PhD (Clinical Psychology), Toronto: Promotion of a biopsychosocial approach (e.g., pain phenotypes, mood, environmental factors) for understanding mechanisms that contribute to the development and maintenance of pain, post-SCI, and the transition to chronicity. 13. Kris Kumar, MD (Neurosurgery), Regina: Surgical management of NeP. 14. Eldon Loh, MD (Physiatry), London: Musculoskeletal and soft tissue pain in SCI. 15. Mary Lynch, MD (Psychiatry), Halifax: Pharmacological management of NeP. 16. Jason McDougall, PhD, Calgary: Basic research into NeP. 17. Dan Marsh, PhD (Physiology), Halifax: Animal models for prevention of NeP. 18. Dwight Moulin, MD (Neurology), London: Leading expert in chronic NeP management. 19. Colleen O’Connell, MD (Physiatry), Fredericton: Evaluating the role of cannabinoids in management of pain. 20. Andy Parrent, MD (Neurosurgery), London: Surgical management of NeP 21. Phillip Peng, MD (Anaesthesia), Toronto: Interventional pain management. 22. Linda Rapson, MD (Acupuncture), Toronto: Leading a trial evaluating the efficacy of acupuncture for treatment of NeP, among individuals with subacute SCI; and exploring the role of vitamin D in pain management. 23. Jana Sawynok, PhD (Pharmacology), Halifax: Basic research in NeP. 24. Christine Short, MD (Physiatry), Halifax: Studying the prevention of neuropathic pain in animal and human models. Evaluating the role of cannabinoids in management of NeP. 25. Eldon Tunks, MD (Psychiatry), Hamilton: Novel approaches to the pharmacologic management of NeP. 26. Mark Ware, MD (Anesthesia), Montréal: Clinical research and health policy implementation related to cannabinoids for treatment of pain. Evaluating the Impact of SCI-related Chronic Pain on Quality of Life and Community Participation Best Practice Indicators A centre of excellence for pain management after SCI should have: 1. An interdisciplinary team with team member interest and experience in managing pain after SCI, including a physiatrist and, possibly other pain specialists (neurosurgery, anaesthesiology). 2. Established, collaborative relationships with chronic pain programs, within facilities/regions. 3. Timely access to a pain specialist and pain management programs (e.g., self management programs, acupuncture, CBT). 4. Routine pain assessments using standardized assessment and outcome tools (e.g., DN4, LANNS, BPI, ORT, Health Related QOL, etc.). 5. An evidence-based approach to patient treatment, with developed pathways that maximize both non-pharmacologic and pharmacologic treatments (using Guidelines for the management of NeP, including SCIRE). 112 CAPTURING CAPACITY IN CANADIAN SCI REHABILITATION


K - Ameliorate Neuropathic Pain
To see the actual publication please follow the link above